The Valley Desk

ArticleEuropean journal of gynaecological oncologyPublished

Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Penn Medicine. Affiliation source

Institution
Penn Medicine

Publication record

Type
Article
Venue
European journal of gynaecological oncology
Published
Subject terms
Ovarian cancer; Bevacizumab; Overall Survival; Fallopian Tube Cancer; Platinum Sensitivity
PubMed ID
36874058
PubMed Central ID
PMC9980410
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal